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Nutritional aspects in hemodialysis. The results of cross sec- min are strongly correlated with body composition and
tional studies throughout the world indicate that maintenance dialysis outcomes and represent suitable surrogates to
hemodialysis patients are at risk of malnutrition. Longitudinal
follow-up closely the nutritional status of the patients [2].studies show that malnutrition is associated with a reduced life
According to threshold values of 35 g/L for albumin andexpectancy mainly because of cardiovascular and infectious
complications. Several factors are responsible for malnutrition 300 mg/L for prealbumin, recent data from France on
of hemodialysis patients. Protein-energy intake is often reduced more than 7000 hemodialyzed patients indicated that 20
because of inappropriate dietary restrictions, anorexia, and
or 36%, respectively, of them suffered from malnutritiontaste alterations, promoting malnutrition in most patients en-
despite satisfying dialysis adequacy (mean Kt/V 1.36 6tering dialysis. Intercurrent illnesses and frequent hospitaliza-
tions add to meal disturbances. A state of persistent catabolism 0.36). In this study, the mean normalized protein nitro-
may result from acidosis, resistance to anabolic factors such as gen appearance (nPNA) was 1.13 6 0.32 g/kg/day; how-growth hormone, insulin, and insulin-like growth factor-1, as
ever, 35% of patients had a nPNA below 1 g/kg/day [3].well as a chronic inflammatory state caused by dialysis mem-
brane and fluid bioincompatibility. In addition, losses of nutri-
ents, including glucose, amino acids, proteins, and vitamins,
occur during the dialysis treatment. Careful monitoring of di- CONSEQUENCES OF MALNUTRITION ON
etary intakes is mandatory even in predialysis patients. In he- DIALYSIS OUTCOMESmodialysis patients, the dose of dialysis should be adapted to
correct acidosis and to relieve anorexia caused by accumulation While reported annual mortality rates range from
of uremic toxins and hyperleptinemia. When malnutrition is 23.6% in the United States in 1993 [4], to 10.7% in
established, active therapeutic interventions should take place,
Europe [5], and to 9.5% in Japan in 1994 [6], a commonincluding intradialytic parenteral nutrition if oral supplementa-
factor of increased death risk in these populations istion has failed to improve nutritional status. Anabolism has
been observed during the administration of recombinant growth malnutrition [7]. Serum albumin below 35 g/L [2, 8–10]
hormone and insulin-like growth factor-1. Emerging therapeu- and serum prealbumin below 300 mg/L (abstract; Chiap-
tic strategies against malnutrition may also involve a short
pini et al, Nephrol Dial Transplant 5:699, 1990) [2, 11–13]period of daily dialysis.
have been shown to be independent predictors of in-
creased morbidity and mortality.
An early report from 98 nondiabetic hemodialysis pa-End-stage renal disease (ESRD) patients treated by
tients followed for 12 months showed an inverse relation-maintenance hemodialysis (MHD) are at risk of malnu-
ship between the protein nitrogen appearance and thetrition, as shown by several cross sectional studies in the
United States, Japan, and Europe. In fact, virtually every frequency of hospitalizations and mortality rate [14]. In
study examining the nutritional status of hemodialysis 1990, Lowrie and Lew showed that in over 12,000 MHD
patients indicates that such patients frequently manifest patients followed for 12 months, of various predialysis
protein calorie malnutrition [1]. The clinical evidence serum chemistries, the serum albumin exhibited the most
for malnutrition includes decreased relative body weight, striking odds ratio for survival [15]. The multicenter Ca-
skinfold thickness, arm muscle circumference, and low nadian Hemodialysis Morbidity Study reported a direct
growth rates in children (Table 1). Body composition correlation between the serum albumin level and the
measurements using total body nitrogen, bioelectrical morbidity and mortality risk in 486 hemodialysis patients
impedance measurements, and dual-energy x-ray absorp- [16]. Two other recent studies also confirm that a low
tiometry (DEXA) also reveal a high incidence of protein
serum albumin concentration is a strong predictor of
calorie malnutrition. Serum levels of albumin and prealbu-
high death rates [17, 18].
A follow-up from the large French multicenter study
Key words: malnutrition, diet and dialysis, growth factors, uremia. on a representative subset of more than 1600 patients
reported a survival of 90 and 78% at one and two years,Ó 2000 by the International Society of Nephrology
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Table 1. Nutritional parameters in chronic hemodialysis patients Table 2. Factors of malnutrition in chronic hemodialysis patients
Clinical Biological Previous malnutrition
Reduced protein-energy intakes
Body weight Serum urea/creatinine Inadequate diet counseling
Skinfold thickness nPNA Anorexia
Arm muscle circumference Serum albumin Taste disturbances
Subjective Global Assessment Serum prealbumin Digestive side-effects of drugs
Growth rate (children) Transferrin Frequent hospitalizations
Cholesterol Primary/intercurrent illnesses
IGF-1 Reduced dietary intakes
Total body nitrogen Catabolic state
Bioelectrical impedance Chronic inflammation
Dual energy x-ray absorptiometry Endocrine and metabolic disorders
Acidosis
Anemia
Uremic toxins
Hyperparathyroidism
respectively, and confirmed a significant influence of se- Hyperleptinemia
Growth hormone and IGF-1 resistancerum levels of albumin and prealbumin on survival (ab-
Dialysis-related eventsstract; Combe et al, J Am Soc Nephrol 10:239A, 1999) [3]. Inadequate Kt/V
It should be emphasized that these findings do not Bioincompatible membranes
Chronic inflammationindicate that improving nutritional status by increasing
Endotoxin back-filtrationnutritional intake or other maneuvers will reduce mor- Amino acid and protein losses
bidity or mortality. Malnutrition by itself is rarely re- Vitamin losses
ported as a cause of death in ESRD patients. In fact,
malnutrition itself may be detrimental on outcomes of
infectious and cardiovascular complications. It is also
either referred for checkup or following surgery overallpossible that the same illnesses that engender malnutri-
received only 80% of the scheduled meals, thus resultingtion will independently cause the high morbidity and
in a weekly deficit of about 2800 kcal per patient. Themortality, therefore reducing the pathogenetic weight of
reasons for those missed meals were, for example, fastingmalnutrition per se.
states before diagnosis procedures or surgery, modified
schedule of dialysis sessions, postdialysis fatigue, and
FACTORS OF MALNUTRITION IN inadequacy between meals and patient’s preferences. It
HEMODIALYSIS PATIENTS is therefore not surprising that in the French cohort,
A high prevalence of protein calorie malnutrition is malnutrition was observed significantly more often in
observed in patients commencing hemodialysis (Table 2) patients with diabetic and vascular kidney disease, even
[19]. Those hemodialysis patients who are malnourished after adjustment for age [3]. Before starting maintenance
at the onset of dialysis therapy are likely to stay malnour- dialysis therapy, low-protein and low-phosphate diets
ished one to two years later. Conversely, those individu- are routinely prescribed. These diets may be sometimes
hypocaloric [27, 28] and therefore may be deleterious toals who are well nourished at the onset of maintenance
the patient’s nutritional status, if not adequately moni-dialysis therapy are likely to remain well nourished.
tored by skilled dietitians.Malnutrition can result from several factors that can
The most important cause of inadequate nutrient in-be found in different combinations in selected patients,
take is almost certainly anorexia. Anorexia may beand it involves reduced dietary intakes, metabolic disor-
caused by many factors, including: uremic toxins; gastro-ders, and inadequate dialysis [20] in terms of dose [21, 22]
intestinal disorders such as peptic ulcers, gastritis, oror membrane biocompatibility [23, 24].
esophagitis; unpalatable medicines; and psychosocial dis-
orders [20, 29, 30].
DIETARY NUTRIENT INTAKE Recent evidence suggest that protein calorie malnutri-
There are many possible causes for protein calorie tion often begins incipiently when the glomerular filtra-
malnutrition in patients receiving maintenance dialysis tion rate (GFR) is about 28 to 35 mL/min/1.73 m2 or
therapy. These patients are chronically exposed to the even higher (abstract; Kopple et al, J Am Soc Nephrol
risk of inadequate diet counseling or self-designed re- 5:335, 1994) and continues to fall gradually as the GFR
strictions, and repeated hospitalizations (abstract; Young decreases below these values [31, 32]. However, patients
et al, J Am Soc Nephrol 10:259A, 1999) [25], which dis- usually do not become frankly malnourished until the
turb dietary habits and reduce dietary nutrient intake, GFR is 4 to 5 mL/min/1.73 m2 or lower. As a result, pre-
and superimposed acute or chronic illnesses [26]. We ESRD patients often have critically low levels of protein
and energy intakes, and the spontaneous nutrient intakehave observed in our unit that hemodialysis patients
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does not normalize when maintenance dialysis treatment benefits of maneuvers designed to enhance the removal
of uremic toxins through increased dialysis eliminationis started. Jacob et al reported that 45% of 61 MHD
patients had a protein intake less than 1.0 g/kg body or adsorption. A specific goal should be to lower plasma
leptin by increasing dialysis clearance or decreasing itsweight/day [33], whereas Bergstro¨m et al found that 12%
of 117 unselected hemodialysis patients had a protein overproduction, which is likely associated with chronic
inflammation [44].intake below 0.8 g/kg body weight/day [30]. A recent
report of the HEMO pilot study in hemodialysis patients
entering dialysis showed a low energy intake (22.8 kcal/kg
NUTRITIONAL CONSEQUENCES OFbody weight/day) and a protein intake of 0.94 g/kg body
CHRONIC INFLAMMATIONweight/day, much less than the 35 kcal/kg body weight/
In patients with chronic renal failure (CRF), chronicday usually recommended for hemodialysis patients or
inflammation may be associated with immunologically-normal individuals [34, 35]. These protein energy intakes
mediated primary renal diseases, treated by corticoste-may strongly affect early outcomes of renal replacement
roids, which in turn induces a well-known catabolic state.therapy and explain why long-term hemodialysis patients
However, an important factor is likely repeated in-are frequently malnourished.
flammatory bursts caused by bioincompatibility of dial-A progressive decrease in protein calorie intake may
ysis membranes and fluids. The quality of dialysis wateralso depend on taste disturbances. The neuroregulation
and dialysis fluid backfiltration play a major role, as sug-of appetite is far from well understood in patients with
gested by cross-sectional studies in which plasma C-reac-chronic renal failure [36]. Zinc deficiency contributes to
tive protein levels are significantly higher in patients treatedtaste disturbances [37, 38]. It has also been suggested
by low-flux hemodiafiltration than in patients treatedthat, in addition to factors such as delayed gastric empty-
by either high-flux hemodiafiltration, paired filtrationing, poorly palatable diets enhanced by salt and electro-
dialysis, or conventional hemodialysis [46]. C-reactivelyte restrictions, and postdialysis malaise, some uremic
protein is an acute phase reactant protein synthesized bytoxins appear to affect appetite directly. Anderstam et
the liver in response to inflammatory processes leading toal recently infused uremic ultrafiltrate into the peritoneal
an increase in IL-6 production. As a result, synthesis ofcavity of rats. Compared with rats infused with saline or
acute phase reactants by the liver is associated with aplasma ultrafiltrate from healthy humans, the rats in-
decreased albumin production [47]. Moreover, chronicfused with uremic ultrafiltrate demonstrated a net reduc-
inflammatory status likely increases lipid and proteintion in their spontaneous food intake [39]. Ultrafiltrate
oxidation, and probably contributes to vascular diseasefractionation studies suggest that the molecular weight
and tissue amyloid deposition [48, 49].of compounds that may induce anorexia is between 1000
and 5000 D [39]. Another compound called leptin, a 15 kD
polypeptidic hormone synthesized by adipocytes, has
DIALYSIS-RELATED NUTRIENT LOSSESbeen shown to decrease appetite in rats and to induce
The hemodialysis procedure itself may promote wast-weight loss when administered as a recombinant product
ing by removing nutrients and also by stimulating proteinin obese humans [40]. Leptin is abnormally high in hemo-
catabolism. Hemodialysis increases the urea nitrogen ap-dialysis patients as a consequence of reduced renal clear-
pearance (UNA or net urea generation), enhances netance, elevated insulin levels, and possibly chronic inflam-
protein breakdown, and promotes negative nitrogen bal-mation [41–44].
ance [50]. During sham hemodialysis in normal volun-These observations suggest that more intensive dial-
teers, Guttierez et al reported an increased release ofysis therapy might increase appetite by removing uremic
amino acids from the leg, indicating enhanced net muscletoxins. Lindsay and Spanner increased the dose of dial-
protein breakdown [51]. The bioincompatible nature ofysis in a group of hemodialysis patients and observed a
dialyzer membranes may stimulate the release of cyto-spontaneous increase in proteic catabolic rate without
kines, such as interleukin-1, which may be the cause ofevidence of catabolic events, suggesting that patients had
the enhanced protein catabolism.increased their protein intake [45]. On the other hand,
During a routine hemodialysis treatment using a low-in many patients, the proteic catabolic rate does not
flux cuprophane membrane, 4 to 9 g of free amino acidsbecome normal when the Kt/V is increased. Although
are lost through the dialyzer during fasting and 8 to 10 gthis might reflect the fact that Kt/V is not sufficiently
if patients are eating during the procedure [52, 53]. Pep-high in these patients, it is possible that comorbid factors,
tides are also removed in a range of 2 to 3 g per dialysispoorly dialyzable compounds, or other factors may con-
[53], thus leading to a net amino acid of 10 to 13 g pertribute to the anorexia and that a high dose of dialysis,
dialysis [30]. With high-flux dialyzers in fasting patients,within a range that is attainable routinely may improve
about 8 g of free amino acids are removed during abut not eradicate anorexia in many patients.
Further studies are needed to evaluate the nutritional routine hemodialysis treatment [54]. However, the use
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Table 3. Therapeutic nutritional interventionsof high-flux membranes with an increased permeability
to protein may result in albumin losses as high as 25 g Interventions
per session when highest ultrafiltration rates are used Adequate dialysis dose
Daily dialysisduring hemodiafiltration (abstract; Hillion et al, J Am
Correction of acidosisSoc Nephrol 10:283A, 1999).
Oral/enteral dietary supplements
Reuse of dialyzers is a routine procedure in the United Parenteral nutrition
InterdialyticStates [55]. Although usually small amounts of protein
Intradialytic rHu-EPOare lost during a single hemodialysis, Kaplan et al re-
rHu-GH
ported markedly increased protein losses when polysul- rHu-IGF
fone membranes were reprocessed many times with
bleach or formaldehyde [56]. After 20 to 25 reuses, up
to 17 g of protein were lost during one hemodialysis
session. Protein losses do not seem to increase markedly failure patients, increases protein catabolism [73, 74].
until reprocessing exceed 10 times. Interestingly, when Metabolic acidosis impairs protein metabolism by mainly
the use of bleach for dialyzer reprocessing was discon- increasing protein catabolism through a stimulation of
tinued, the patients underwent a significant increase in the ubiquitin-proteasome pathway. In addition, acidosis
serum albumin, from 3.6 to 3.8 g/dL, which was consid- increases insulin resistance and impairs the effects of
ered to be due to reduced protein leakage through the insulin on glucose and amino acid utilization. Acidosis
dialyzers [56]. is also partially corrected by a low-protein diet [75].
During hemodialysis with glucose-free dialysate, an
average of 20 to 30 g of glucose is lost into the dialysate
PERSPECTIVES FOR[57, 58]. If a dialysate containing 200 mg/dL (11 mmol/L)
NUTRITIONAL INTERVENTIONSof glucose monohydrate (180 mg/dL of anhydrous glu-
In face of numerous causes for malnutrition, it is notcose) is used, there is a net absorption of 10 to 30 g of
unexpected to find many different treatments for malnu-glucose during each dialysis [57, 58].
trition. Some are still experimental, although pilot stud-Deficiency of water-soluble vitamins in hemodialysis
ies appear promising (Table 3).patients results primarily from insufficient intake, losses
A low serum bicarbonate level may be associated withinto dialysate, or altered vitamin synthesis or metabolism
higher protein intakes [3], and it is unclear from clinicalor possibly the presence of inhibitors to the actions of
studies whether those patients have a higher benefit ofthe vitamins. Water-soluble vitamins and other bioactive
larger protein intakes as compared with the detrimentalcompounds are removed by both hemodialysis and peri-
catabolism induced by acidosis per se. However, sincetoneal dialysis [59–62]. These losses may be reduced by
dietary protein intake is not easy to assess routinely anddecreased urinary excretion and may be partially re-
because nPNA may not be a valid marker of proteinplaced by the vitamins provided in a normal diet [63–68].
intake in acidosis (for example, a nonstable metabolicIf patients have low nutrient intakes, these losses may
state), acidosis control should be advised, through oralenhance malnutrition. In fact, the content of several vita-
or dialytic route, to reach a minimum predialytic serummins in typical meals ingested by MHD patients is less
bicarbonate level of 22 mmol/L.than the Recommended Dietary Allowances of the Food
Oral and enteral dietary supports are generally notand Nutrition Board. However, the need of water-solu-
largely prescribed because of moderate taste acceptabil-ble vitamins may vary with the new types of dialyzers
ity, patients getting tired of them, and products overcost.used. The more porous, high-flux dialyzers remove greater
In addition, a number of patients may present gastroin-quantities of vitamins. Some of the detrimental effects
testinal discomfort or disease and may not benefit fromof losses of water soluble vitamins and other compounds
these compounds. However, oral supplements may pre-might be alleviated by either intradialytic supplementa-
vent the setting of malnutrition particularly due to lowtion [69] or convective dialysis methods associated with
energy intakes and should therefore be proposed system-reinfusion of regenerated ultrafiltrate.
atically before any intravenous nutrition therapy, be-
cause of almost no side effects and potential benefits. In
IMPAIRED UTILIZATION OF NUTRIENTS particular states of severe malnutrition, we and others
Endocrine and metabolic disorders are frequently ob- have observed unexpected recoveries after gastrostomy
served during chronic renal failure. There is a state of and sustained enteral nutrition.
resistance to many anabolic hormones, including insulin, Parenteral nutrition, either predialytic (IDPN) or con-
growth hormone, and insulin-like growth factor-1 (IGF-1) tinuous (TPN), has been proposed in response to the
[70–72]. failure of increasing oral nutrients intake. Except during
specific conditions such as surgery, trauma, severe sepsis,Acidemia, a condition frequently observed in renal
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4. Held PJ, Brunner FB, Odaka M, Garcia JR, Port FK, Gaylinor chronic digestive disease where this intravenous sup-
DS: Five-year survival for end-stage renal disease patients in the
port will maintain an optimal intake, there are no con- United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis
15:451–457, 1990vincing randomized controlled studies supporting the use
5. Valderrabano F, Berthoux F, Jones E, Mehls O: Report onof long-term intravenous nutrition [76]. Furthermore,
management of renal failure in Europe, XXV, 1994: End stage
side effects may occur such as nausea, malaise, liver test renal disease and dialysis report. Nephrol Dial Transplant 11(Suppl
1):2–21, 1996abnormalities, and sepsis, and in one study, IDPN has
6. Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaokabeen associated with outcome worsening in patients with
T, Kubo K, Shinoda T, Kurokawa K, Marumo F, Sato T, Maeda
a serum albumin of greater than 35 g/L [77]. However, K: Survival in long term haemodialysis patients: Results of the
annual survey of the Japanese society for dialysis therapy. Nephrolthe fact that nutrients could be delivered without extra
Dial Transplant 12:884–888, 1997hospitalization and venous access during a regular dial-
7. Bergstro¨m J: Nutrition and mortality in hemodialysis. J Am Soc
ysis, that new delivery systems and solutions (all-in-one) Nephrol 6:1329–1341, 1995
8. Iseki K, Kawazoe N, Fukiyama K: Serum albumin is a strongare proposed, and new formulas are under development
predictor of death in chronic dialysis patients. Kidney Int 44:115–still represent a large potential for future treatments,
119, 1993
which should be adequately validated through clinical 9. Goldwasser P, Mittman N, Antignani A, Burrell D, Michel
MA, Collier J, Avram MM: Predictors of mortality in hemodialy-trials of best quality.
sis patients. J Am Soc Nephrol 3:1616–1622, 1993In order to stimulate protein synthesis, anabolic com-
10. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC,
pounds have been administered during limited pilot trials Barre PE: Hypoalbuminemia, cardiac morbidity, and mortality in
end-stage renal disease. J Am Soc Nephrol 7:728–736, 1996in maintenance dialysis patients. It is now well accepted
11. Oksa H, Ahonen K, Pasternak A, Marnela KM: Malnutritionthat recombinant growth hormone (rhGH) exerts a in hemodialysis patients. Scand J Urol Nephrol 25:157–161, 1991
strong anabolic effect in chronic renal failure children, 12. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P:
Markers for survival in dialysis: A seven-year prospective study.and benefits on growth and body composition have
Am J Kidney Dis 26:209–219, 1995largely overcome limited side effects and high costs of 13. Sreedhara R, Avram MM, Blanco M, Batish R, Avram MM,
treatment [78]. In chronic renal failure adults, rhGH has Mittman N: Prealbumin is the best nutritional predictor of survival
in hemodialysis and peritoneal dialysis. Am J Kidney Dis 28:937–been associated with anabolic response during acute and
942, 1996chronic administration [79–81]. Since IGF-1 is the active 14. Acchiardo SR, Moore LW, Latour PA: Malnutrition as the main
compound released by growth hormone, rhIGF-1 has factor of morbidity and mortality in hemodialysis patients. Kidney
Int 24(Suppl 16):S199–S203, 1983also been administered in adult chronic renal failure
15. Lowrie EG, Lew LN: Death risk in hemodialysis patients: Thepatients and showed anabolic properties as well [82]. predictive value of commonly measured variables and an evalua-
Long-term administration of these compounds in adult tion of death rate differences between facilities. Am J Kidney Dis
5:458–482, 1990MHD patients are still lacking, but it seems reasonable
16. Churchill DN, Taylor DW, Cook RJ, Laplante P, Barre P,to try to boost the nutritional response by a short-term Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H: Cana-
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